Literature DB >> 417032

Rat model of experimental endocarditis.

J Santoro, M E Levison.   

Abstract

A simple model of infective endocarditis was produced in rats. With the aid of a guide wire, polyethylene catheters were passed into the left ventricle through the right carotid artery of Sprague-Dawley rats weighing 300 to 350 g. A volume of 1 ml of an overnight culture of Streptococcus mitis, Staphylococcus aureus, or Streptococcus faecalis was intravenously injected 1 to 2 days after catheterization. Bacterial titers of Streptococcus mitis in vegetations were about 10(4)-fold greater than in other tissues. Blood cultures were always positive after 6 h. Mortality was 19% at 1 week and 82% at 2 weeks. Catheters were pulled 24 h after infection, and vegetation titers of greater than 7.0 log10 colony-forming units per g were sustained at 5 days. In intravenously infected rats without catheters, blood and tissues were sterile after 3 to 5 days. With Staphylococcus aureus, vegetations had greater than 9.0 log10 colony-forming units and with Streptococcus faecalis 8.8 +/- 0.3 log10 colony-forming units per g at 2 days. The rat model of infective endocarditis should prove to be suitable for further pathological and therapeutic studies.

Entities:  

Mesh:

Year:  1978        PMID: 417032      PMCID: PMC422278          DOI: 10.1128/iai.19.3.915-918.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Susceptibility to Streptococcus viridans endocarditis in rabbits with intracardiac pacemaker electrodes or polyethylene tubing.

Authors:  D Tanphaichitra; K Ries; M E Levison
Journal:  J Lab Clin Med       Date:  1974-11

2.  Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.

Authors:  D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

3.  Antibiotic concentrations in serum, serum bactericidal activity, and results of therapy of streptococcal endocarditis in rabbits.

Authors:  J Carrizosa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

4.  Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.

Authors:  J Egert; J Carrizosa; D Kaye; W D Kobasa
Journal:  J Lab Clin Med       Date:  1977-06

5.  Antibiotic synergism in enterococcal endocarditis.

Authors:  J Carrizosa; D Kaye
Journal:  J Lab Clin Med       Date:  1976-07
  5 in total
  42 in total

1.  In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.

Authors:  H W Boucher; C Thauvin-Eliopoulos; D Loebenberg; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Invasion and killing of human endothelial cells by viridans group streptococci.

Authors:  Murray W Stinson; Susan Alder; Sarmishtha Kumar
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Guinea pig model for Staphylococcus aureus native valve endocarditis.

Authors:  M Maurin; H Lepidi; B La Scola; M Feuerstein; M Andre; J F Pellissier; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Contribution of sialic acid-binding adhesin to pathogenesis of experimental endocarditis caused by Streptococcus gordonii DL1.

Authors:  Yukihiro Takahashi; Eizo Takashima; Kisaki Shimazu; Hisao Yagishita; Takaaki Aoba; Kiyoshi Konishi
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.

Authors:  J C Lee; J S Park; S E Shepherd; V Carey; A Fattom
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

6.  In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.

Authors:  M Souli; C Thauvin-Eliopoulos; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

7.  In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.

Authors:  G M Eliopoulos; S Willey; E Reiszner; P G Spitzer; G Caputo; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

8.  Natural history of aortic valve endocarditis in rats.

Authors:  E Héraïef; M P Glauser; L R Freedman
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

9.  Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin.

Authors:  F T Counter; P W Ensminger; D A Preston; C Y Wu; J M Greene; A M Felty-Duckworth; J W Paschal; H A Kirst
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

10.  Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.

Authors:  C Thauvin-Eliopoulos; L B Rice; G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.